Animal models of Parkinson's disease: Similarities and differences between the disease and models

Neuropathology

Volumn 27, Issue 5, 2007, Pages 479-483

  Hattori, Nobutaka ^a   Sato, Shigeto ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Alpha synuclein; Parkin; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; NEUROTOXIN; PARKIN; PRION PROTEIN; PROTEASOME INHIBITOR; ROTENONE; VESICULAR MONOAMINE TRANSPORTER;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE MODEL; DROSOPHILA; GENE; GENETIC IDENTIFICATION; GENETIC MODEL; HUMAN; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; RECESSIVE INHERITANCE; SNCA GENE;

ANIMALS; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GENES, RECESSIVE; HUMANS; MODELS, GENETIC; NEUROTOXINS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA;

EID: 34648819361     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00842.x     Document Type: Conference Paper

References (19)

1. Rocca WA, Peterson BJ, McDonnell SK et al. The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics. Neuroepidemiology 2005 24 : 151 167.
2. Sato K, Hatano T, Yamashiro K et al. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 2006 21 : 1384 1395.
3. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 2004 318 : 215 224.
4. Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Complex I and Parkinson's disease. IUBMB Life 2001 52 : 135 141.
5. McNaught KS, Olanow CW. Proteasome inhibitor-induced model of Parkinson's disease. Ann Neurol 2006 60 : 243 247.
6. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000 3 : 1301 1306.
7. Nieto M, Gil-Bea FJ, Dalfo E et al. Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 2006 27 : 848 856.
8. Dong Z, Ferger B, Feldon J, Bueler H. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. J Neurobiol 2002 53 : 1 10.
9. Richfield EK, Thiruchelvam MJ, Cory-Slechta DA et al. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol 2002 175 : 35 48.
10. Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000 287 : 1265 1269.
11. Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature 2000 404 : 394 398.
12. Chartier-Harlin MC, Kachergus J, Roumier C et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004 364 : 1167 1169.
13. Farrer M, Kachergus J, Forno L et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004 55 : 174 179.
14. Ibanez P, Bonnet AM, Debarges B et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004 364 : 1169 1171.
15. Nishioka K, Hayashi S, Farrer MJ et al. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol 2006 59 : 298 309.
16. Periquet M, Corti O, Jacquier S, Brice A. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 2005 95 : 1259 1276.
17. Itier JM, Ibanez P, Mena MA et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 2003 12 : 2277 2291.
18. Goldberg MS, Fleming SM, Palacino JJ et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 2003 278 : 43628 43635.
19. Sato S, Chiba T, Nishiyama S et al. Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography. J Neurosci Res 2006 84 : 1350 1357.